Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03085095
Brief Title: A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer (HERO)

First Submitted : March 9, 2017
First Submitted that Met QC Criteria : March 14, 2017
First Posted : March 21, 2017

Results First Submitted : January 19, 2021
Results First Submitted that Met QC Criteria : March 2, 2021
Results First Posted : March 25, 2021

Certification/Extension First Submitted : October 5, 2020
Certification/Extension First Submitted that Met QC Criteria : March 2, 2021
Certification/Extension First Posted : March 25, 2021

Last Update Submitted that Met QC Criteria : March 2, 2021
Last Update Posted : March 25, 2021